Jeffrey McGroarty
2021
In 2021, Jeffrey McGroarty earned a total compensation of $5M as Chief Financial Officer at Annovis Bio, a 377% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $148,500 |
|---|---|
| Option Awards | $4,503,084 |
| Salary | $315,000 |
| Other | $11,600 |
| Total | $4,978,184 |
McGroarty received $4.5M in option awards, accounting for 90% of the total pay in 2021.
McGroarty also received $148.5K in non-equity incentive plan, $315K in salary and $11.6K in other compensation.
Rankings
In 2021, Jeffrey McGroarty's compensation ranked 2,633rd out of 12,415 executives tracked by ExecPay. In other words, McGroarty earned more than 78.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,633 out of 12,415 | 79th |
Division Manufacturing | 1,041 out of 5,505 | 81st |
Major group Chemicals And Allied Products | 406 out of 2,375 | 83rd |
Industry group Drugs | 356 out of 2,096 | 83rd |
Industry Pharmaceutical Preparations | 233 out of 1,546 | 85th |
Source: SEC filing on April 18, 2022.
McGroarty's colleagues
We found one more compensation record of an executive who worked with Jeffrey McGroarty at Annovis Bio in 2021.
2021
Maria Maccecchini
Annovis Bio